Review of the literature on strategies for the prevention of Monkeypox in Chile: New challenges

Review of the literature on strategies for the prevention of Mpox in Chile: New challenges

Authors

  • Constanza Zúñiga Pizarro Universidad Andres Bello
  • Beatriz Muñoz Vásquez Universidad Andrés Bello
  • Catalina Recabarren Dueñas Universidad Andrés Bello
  • Felipe Jimenez Durán Universidad Andrés Bello
  • Sebastián Zúñiga Pizarro CESFAM Sur Iquique

DOI:

https://doi.org/10.56754/0718-9958.2024.223

Keywords:

Mpox, Vaccination, zoonoses, Epidemiology, Public health

Abstract

Review of the literature on strategies for the prevention of Monkeypox in Chile: New challenges

 

ABSTRACT

Introduction:

Monkeypox (Mpox) is an emerging zoonotic disease with demonstrated potential for global spread, affecting regions outside its endemic areas in Africa. In Chile, although there have been no endemic outbreaks, the presence of imported cases highlights the need for effective preventive measures to prevent its dissemination.

 

Results:

Second- and third-generation vaccines, initially developed to combat smallpox, have shown efficacy in preventing and mitigating the symptoms of Mpox. Active epidemiological surveillance and contact tracing are essential for the early identification of imported cases and the prevention of local transmission. Additionally, a shift in the mode of transmission of the virus has been observed, now predominantly associated with sexual contact, which requires adjustments in preventive strategies.

 

Discussion:

The experience gained during the COVID-19 pandemic has demonstrated Chile's capacity to respond to health emergencies, which is encouraging for facing potential endemic outbreaks. Continuously adapting and updating public health policies, combined with effective vaccination and public education strategies, is essential for addressing any emerging threats posed by this virus. The findings of this review highlight the importance of a proactive and coordinated approach to the prevention and control of Mpox, thus ensuring the protection of public health in Chile.

 

Keywords: Mpox, vaccination, zoonoses, epidemiology, public health.

References

Sabeena S. The changing epidemiology of monkeypox and preventive measures: an update. Arch Virol. 2023 Jan 5;168(1):31. doi: 10.1007/s00705-022-05677-3. PMID: 36604361.

Lu J, Xing H, Wang C, Tang M, Wu C, Ye F, Yin L, Yang Y, Tan W, Shen L. Mpox (formerly monkeypox): pathogenesis, prevention, and treatment. Signal Transduct Target Ther. 2023 Dec 27;8(1):458. doi: 10.1038/s41392-023-01675-2. PMID: 38148355; PMCID: PMC10751291.

Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, Steffen R. The changing epidemiology of human monkeypox-A potential threat? A systematic review. PLoS Negl Trop Dis. 2022 Feb 11;16(2):e0010141. doi: 10.1371/journal.pntd.0010141. PMID: 35148313; PMCID: PMC8870502.

Díaz FP, editor. Decreta alerta sanitaria y otorga facultades extraordinarias que señala por emergencia de salud pública de importancia internacional (ESPII) derivada por brote de viruela símica. Vol. 43.935. DIARIO OFICIAL DE LA REPÚBLICA DE CHILE: 2024.

Yinka-Ogunleye A, Aruna O, Dalhat M, Ogoina D, McCollum A, Disu Y, Mamadu I, Akinpelu A, Ahmad A, Burga J, Ndoreraho A, Nkunzimana E, Manneh L, Mohammed A, Adeoye O, Tom-Aba D, Silenou B, Ipadeola O, Saleh M, Adeyemo A, Nwadiutor I, Aworabhi N, Uke P, John D, Wakama P, Reynolds M, Mauldin MR, Doty J, Wilkins K, Musa J, Khalakdina A, Adedeji A, Mba N, Ojo O, Krause G, Ihekweazu C; CDC Monkeypox Outbreak Team. Outbreak of human monkeypox in Nigeria in 2017-18: a clinical and epidemiological report. Lancet Infect Dis. 2019 Aug;19(8):872-879. doi: 10.1016/S1473-3099(19)30294-4. Epub 2019 Jul 5. PMID: 31285143; PMCID: PMC9628943.

Sklenovská N, Van Ranst M. Emergence of Monkeypox as the Most Important Orthopoxvirus Infection in Humans. Front Public Health. 2018 Sep 4;6:241. doi: 10.3389/fpubh.2018.00241. PMID: 30234087; PMCID: PMC6131633.

Marraha F, Al Faker I, Chahoub H, Benyamna Y, Rahmani N, Gallouj S. Monkeypox 2022 Outbreak: How Alarming Is the Situation? Epidemiological and Clinical Review. Clin Pract. 2023 Jan 13;13(1):102-115. doi: 10.3390/clinpract13010010. PMID: 36648850; PMCID: PMC9844383.

Vaughan A, Aarons E, Astbury J, Balasegaram S, Beadsworth M, Beck CR, Chand M, O'Connor C, Dunning J, Ghebrehewet S, Harper N, Howlett-Shipley R, Ihekweazu C, Jacobs M, Kaindama L, Katwa P, Khoo S, Lamb L, Mawdsley S, Morgan D, Palmer R, Phin N, Russell K, Said B, Simpson A, Vivancos R, Wade M, Walsh A, Wilburn J. Two cases of monkeypox imported to the United Kingdom, September 2018. Euro Surveill. 2018 Sep;23(38):1800509. doi: 10.2807/1560-7917.ES.2018.23.38.1800509. PMID: 30255836; PMCID: PMC6157091.

Català A, Riera J, Fuertes I. Mpox - Formerly Monkey Pox - in Dermatology: A Review of Epidemiologic Features, Clinical Presentation, Diagnosis, and Treatment. Actas Dermosifiliogr. 2023 Apr;114(4):318-326. English, Spanish. doi: 10.1016/j.ad.2023.01.002. Epub 2023 Jan 20. PMID: 36682683; PMCID: PMC9854265.

Franco L. AO, Moreno-Samper D, Chaparro-Mérida NA. Viruela del simio. Rev Chilena Infectol [Internet]. 2022 [citado el 03 de agosto de 2024]; 39(4):457–66. Disponible en: https://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-10182022000400457

MINISTERIO DE SALUD. Orientación Técnica del Manejo clínico de Viruela Símica. 1ra Edición. 2022

Jarosz D, Grudzińska A, Dudzińska P, Milanowska M, Tsitko H. Monkeypox - new epidemiological threat? Review of the current literature. J Educ Health Sport [Internet]. 2023 Jan. 25 [citado el 03 de agosto de 2024];13(3):128-33. Disponible en: https://apcz.umk.pl/JEHS/article/view/41682

Lopera JG, Falendysz EA, Rocke TE, Osorio JE. Attenuation of monkeypox virus by deletion of genomic regions. Virology. 2015 Jan 15;475:129-38. doi: 10.1016/j.virol.2014.11.009. Epub 2014 Dec 1. PMID: 25462353; PMCID: PMC4720520.

Mpox [Internet]. World Health Organization. 2024 [citado el 26 de agosto de 2024]. Disponible en: https://www.who.int/news-room/fact-sheets/detail/mpox

Reynolds MG, Yorita KL, Kuehnert MJ, Davidson WB, Huhn GD, Holman RC, Damon IK. Clinical manifestations of human monkeypox influenced by route of infection. J Infect Dis. 2006 Sep 15;194(6):773-80. doi: 10.1086/505880. Epub 2006 Aug 8. PMID: 16941343.

Sukhdeo S, Mishra S, Walmsley S. Human monkeypox: a comparison of the characteristics of the new epidemic to the endemic disease. BMC Infect Dis. 2022 Dec 12;22(1):928. doi: 10.1186/s12879-022-07900-7. PMID: 36503476; PMCID: PMC9742013.

Sharma A, Prasad H, Kaeley N, Bondalapati A, Edara L, Kumar YA. Monkeypox epidemiology, clinical presentation, and transmission: a systematic review. Int J Emerg Med. 2023 Mar 17;16(1):20. doi: 10.1186/s12245-023-00491-3. PMID: 36932335; PMCID: PMC10021050.

Di Giulio DB, Eckburg PB. Human monkeypox: an emerging zoonosis. Lancet Infect Dis. 2004 Jan;4(1):15-25. doi: 10.1016/s1473-3099(03)00856-9. Erratum in: Lancet Infect Dis. 2004 Apr;4(4):251. PMID: 14720564; PMCID: PMC9628772.

de la Calle-Prieto F, Estébanez Muñoz M, Ramírez G, Díaz-Menéndez M, Velasco M, Azkune Galparsoro H, et al. Tratamiento y prevención de la viruela del mono. Enferm Infecc Microbiol Clin [Internet]. 2023;41(10):629–34. Disponible en: http://dx.doi.org/10.1016/j.eimc.2022.08.001

Li E, Guo X, Hong D, Gong Q, Xie W, Li T, et al. Duration of humoral immunity from smallpox vaccination and its cross-reaction with Mpox virus. Signal Transduct Target Ther [Internet]. 2023;8(1). Disponible en: http://dx.doi.org/10.1038/s41392-023-01574-6

Asistencia Remota en Salud. D. Mpox [Internet]. Salud Responde. 2024 [citado el 23 de agosto de 2024]. Disponible en: https://saludresponde.minsal.cl/mpox/

MINSAL. Recomendación del CAVEI sobre vacunación contra viruela símica en Chile [publicado el 06 de septiembre de 2022]. Disponible en: https://www.minsal.cl/wpcontent/uploads/2022/09/RecomendacionVacunacio%CC%81n-Viruela-simica-septiembre-2022-Cavei-1.pdf

Su C, Li S, Wen Y, Geng X, Yin Q, Wang Y, Xiong Y, Liu Z. A Quadrivalent mRNA Immunization Elicits Potent Immune Responses against Multiple Orthopoxviral Antigens and Neutralization of Monkeypox Virus in Rodent Models. Vaccines (Basel). 2024 Apr 5;12(4):385. doi: 10.3390/vaccines12040385. PMID: 38675767; PMCID: PMC11053415.

OPS. Opciones terapéuticas para la viruela símica [Internet]. Organización Panamericana de la Salud. 2022 [citado el 24 de agosto de 2024]. Disponible en: https://iris.paho.org/bitstream/handle/10665.2/56406/OPSIMSEIHMonkeypox220023_spa.pdf?sequence=8&isAllowed=y

Arranz Izquierdo J, Molero García JM, Gutiérrez Pérez MI. Manejo desde atención primaria de la infección por la viruela del mono (MPOX) en humanos. Atención Primaria. 2023 Oct;55(10):102680.

Alvarez-Guachichulca JS, Jaramillo-Aguilar DS. Viruela símica: una revisión narrativa de la fisiopatología. Rev Chilena Infectol [Internet]. 2023;40(1):21–7. Disponible en: http://dx.doi.org/10.4067/s0716-10182023000100021

Chile gana premio internacional por el desarrollo de herramientas analíticas contra la pandemia. Prensa UChile [Internet]. Abril de 2022 [Citado el 25 de agosto de 2024] Disponible en: https://uchile.cl/noticias/185180/investigadores-del-isci-ganan-franz-edelman-award-2022

Published

2024-11-18

How to Cite

1.
Zúñiga Pizarro C, Muñoz Vásquez B, Recabarren Dueñas C, Jimenez Durán F, Zúñiga Pizarro S. Review of the literature on strategies for the prevention of Monkeypox in Chile: New challenges: Review of the literature on strategies for the prevention of Mpox in Chile: New challenges. Rev Estud Med Sur [Internet]. 2024 Nov. 18 [cited 2025 Oct. 14];11(2):65-71. Available from: https://rems.ufro.cl/index.php/rems/article/view/223

Similar Articles

1 2 3 4 5 6 7 > >> 

You may also start an advanced similarity search for this article.